Inventor · disambiguated record
Cornelis Johannes Maria Melief
Also filed as: MELIEF CORNELIS J · MELIEF CORNELIS J M · MELIEF CORNELIS JOHANNES · MELIEF CORNELIS JOHANNES M
18 granted patents·12 pending applications·80 citations·filing 2000–2022
93Inventor score
Files withACADEMISCH ZIEKENHUIS LEIDEN12ISA PHARMACEUTICALS B V4UNIV LEIDEN MEDICAL CT3UNIV HOSPITAL LEIDEN2VAN DER BURG SJOERD HENRICUS2
Top patents by PatentIndex Score
30 records- 0189US10450356B2PRAME derived peptides and immunogenic compositions comprising theseACADEMISCH ZIEKENHUIS LEIDEN·Filed 2016·Granted Oct 22, 2019·11 cites·17 claims
- 0284US9314521B2Adjuvant compoundISA PHARMACEUTICALS B V·Filed 2012·Granted Apr 19, 2016·10 cites·18 claims
- 0383US11458198B2HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccinesACADEMISCH ZIEKENHUIS LEIDEN·Filed 2020·Granted Oct 4, 2022·1 cites·19 claims
- 0483US10258684B2HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccinesACADEMISCH ZIEKENHUIS LEIDEN·Filed 2017·Granted Apr 16, 2019·3 cites·17 claims
- 0583US9764023B2HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccinesACADEMISCH ZIEKENHUIS LEIDEN·Filed 2014·Granted Sep 19, 2017·5 cites·18 claims
- 0683US7807369B2Methods and means for the treatment of HPV induced intraepithelial neoplasiaUNIV LEIDEN MEDICAL CT·Filed 2006·Granted Oct 5, 2010·10 cites·11 claims
- 0781US9562075B2Intradermal HPV peptide vaccinationVAN DER BURG SJOERD HENRICUS·Filed 2008·Granted Feb 7, 2017·6 cites·12 claims
- 0880US9770506B2Adjuvant compoundISA PHARMACEUTICALS B V·Filed 2016·Granted Sep 26, 2017·4 cites·21 claims
- 0979US2023256075A1Hpv epitopes targeted by t cells infiltrating cervical malignancies for use in vaccinesACADEMISCH ZIEKENHUIS LEIDEN·Filed 2022·Application pending·0 cites
- 1077US8492514B2PRAME derived peptides and immunogenic compositions comprising theseKESSLER JAN·Filed 2009·Granted Jul 23, 2013·5 cites·18 claims
- 1177US7202034B2Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responsesACADEMISCH ZIEKENHUIS LEIDEN·Filed 2001·Granted Apr 10, 2007·12 cites·16 claims
- 1272US10688173B2HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccinesACADEMISCH ZIEKENHUIS LEIDEN·Filed 2019·Granted Jun 23, 2020·0 cites·16 claims
- 1372US7563445B2CD40 binding molecules and CTL peptides for treating tumorsUNIV HOSPITAL LEIDEN·Filed 2002·Granted Jul 21, 2009·8 cites·15 claims
- 1469US9650423B2Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responsesACADEMISCH ZIEKENHUIS LEIDEN·Filed 2015·Granted May 16, 2017·1 cites·10 claims
- 1565US7560105B1Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigen-specific T cell responsesLEIDS UNI MEDISCH CT·Filed 2000·Granted Jul 14, 2009·4 cites·43 claims
- 1662US8663646B2P53 peptide vaccineVAN DER BURG SJOERD HENRICUS·Filed 2009·Granted Mar 4, 2014·0 cites·5 claims
- 1757US10253073B2Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responsesACADEMISCH ZIEKENHUIS LEIDEN·Filed 2017·Granted Apr 9, 2019·0 cites·9 claims
- 1857US9441025B2Prame derived peptides and immunogenic compositions comprising theseACADEMISCH ZIEKENHUIS LEIDEN·Filed 2013·Granted Sep 13, 2016·0 cites·10 claims
- 1957US2023087422A1Treatment of hpv-related diseasesISA PHARMACEUTICALS B V·Filed 2021·Application pending·0 cites
- 2054US2015010586A1p53 Peptide VaccineACADEMISCH ZIEKENHUIS LEIDEN·Filed 2014·Application pending·0 cites
- 2153US2009285814A1CD 40 Binding Molecules and CTL Pepetides for Treating TumorsUNIV HOSPITAL LEIDEN·Filed 2009·Application pending·0 cites
- 2251US9115185B2Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responsesVAN DER BURG SJOERD HENDRIKUS·Filed 2007·Granted Aug 25, 2015·0 cites·9 claims
- 2350US2017143818A1Intradermal hpv peptide vaccinationACADEMISCH ZIEKENHUIS LEIDEN·Filed 2016·Application pending·0 cites
- 2448US2005255106A1Induction of anti-tumor ctl immunity through in vivo triggering of 4-1bb and/or cd40DIEHL LINDA·Filed 2003·Application pending·0 cites
- 2547US2010189742A1HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccinesACADEMISCH ZIEKENHUIS LEIDEN H·Filed 2010·Application pending·0 cites
- 2646US2023143215A1Immunization against sars-cov-related diseasesISA PHARMACEUTICALS B V·Filed 2021·Application pending·0 cites
- 2745US2011008287A1Methods and means for the treatment of hpv induced intraepithelial neoplasiasUNIV LEIDEN MEDICAL CT·Filed 2010·Application pending·0 cites
- 2845US2003118588A1Induction of anti-tumor CTL immunity through in vivo triggering of 4-1BB and/or CD40Filed 2002·Application pending·0 cites
- 2941US2009220534A1Methods for identifying t-cell epitopes associated with impaired peptide processing and applications of the identified epitopesUNIV LEIDEN MEDICAL CT·Filed 2007·Application pending·0 cites
- 3037US2023242590A1Treatment of diseases related to hepatitis b virusISA PHARMACEUTICALS·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Cornelis Johannes Maria Melief files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →